ArticleClinical and molecular hepatology2025

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C.

Tom Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.